{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:55:33Z","timestamp":1781844933464,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant peritoneal mesothelioma (MPeM) is a rare cancer of the mesothelial cells of the peritoneum. Computed tomography (CT) is considered the standard for first-line imaging of MPeM, diagnosis and risk stratification remains challenging. Peritoneal cancer index (PCI), as assessed by CT, is utilized in the prognostic assessment of other malignant intra-abdominal conditions; however, there is limited data concerning the utility of PCI in the diagnosis and workup of MPeM. We studied a retrospective cohort of all patients diagnosed with MPeM from 2000 to 2012 in Finland. CT and magnetic resonance imaging (MRI) were reviewed and scored by an experienced and blinded, board-certified abdominal radiologist. Additional clinical data and outcomes were obtained from Finnish Cancer Registry (FCR), the Workers\u2019 Compensations Center (WCC), and Statistics Finland (SF). Abdominal CT or MRI was available for 53 of 90 patients. The median radiographic PCI was 25. PCI score was correlated with overall survival (<jats:italic>p<\/jats:italic>\u2009=\u20090.004, Exp(B)\u2009=\u20091.064, 95% CI 1.020\u20131.110). PCI score\u2009\u2265\u200930 was associated with worse survival (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), while PCI\u2009\u2264\u200919 was associated with improved overall survival (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). Our study indicates that radiological PCI is prognostic in MPeM and should be assessed during radiographic workup and integrated into clinical decision-making.<\/jats:p>","DOI":"10.1038\/s41598-020-70044-8","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T10:04:51Z","timestamp":1596708291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study"],"prefix":"10.1038","volume":"10","author":[{"given":"Silja A. S.","family":"Salo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eila","family":"Lantto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjukka","family":"Myll\u00e4rniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo A.","family":"Salo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ilonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"issue":"11","key":"70044_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.21037\/atm.2017.03.96","volume":"5","author":"J Kim","year":"2017","unstructured":"Kim, J., Bhagwandin, S. & Labow, D. M. Malignant peritoneal mesothelioma: a review. Ann. Transl. Med.5(11), 236. https:\/\/doi.org\/10.21037\/atm.2017.03.96 (2017).","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"70044_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/030089160308900307","volume":"89","author":"YI Acherman","year":"2003","unstructured":"Acherman, Y. I., Welch, L. S., Bromley, C. M. & Sugarbaker, P. H. Clinical presentation of peritoneal mesothelioma. Tumori89(3), 269\u2013273 (2003).","journal-title":"Tumori"},{"issue":"2","key":"70044_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jso.21177","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua, T. C., Yan, T. D. & Morris, D. L. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J. Surg. Oncol.99(2), 109\u2013113. https:\/\/doi.org\/10.1002\/jso.21177 (2009).","journal-title":"J. Surg. Oncol."},{"issue":"4","key":"70044_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4149\/neo_2014_053","volume":"61","author":"H Kaya","year":"2014","unstructured":"Kaya, H. et al. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma. Neoplasma61(4), 433\u2013438. https:\/\/doi.org\/10.4149\/neo_2014_053 (2014).","journal-title":"Neoplasma"},{"issue":"5","key":"70044_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.21037\/jgo.2017.08.01","volume":"8","author":"A Garcia-Fadrique","year":"2017","unstructured":"Garcia-Fadrique, A. et al. Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: A review. J. Gastrointest. Oncol.8(5), 915\u2013924. https:\/\/doi.org\/10.21037\/jgo.2017.08.01 (2017).","journal-title":"J. Gastrointest. Oncol."},{"issue":"5","key":"70044_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/028418519103200503","volume":"32","author":"PR Ros","year":"1991","unstructured":"Ros, P. R., Yuschok, T. J., Buck, J. L., Shekitka, K. M. & Kaude, J. V. Peritoneal mesothelioma. Radiologic appearances correlated with histology. Acta Radiol.32(5), 355\u2013358 (1991).","journal-title":"Acta Radiol."},{"issue":"6","key":"70044_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2214\/ajr.140.6.1189","volume":"140","author":"K Reuter","year":"1983","unstructured":"Reuter, K. et al. Diagnosis of peritoneal mesothelioma: computed tomography, sonography, and fine-needle aspiration biopsy. AJR Am. J. Roentgenol.140(6), 1189\u20131194. https:\/\/doi.org\/10.2214\/ajr.140.6.1189 (1983).","journal-title":"AJR Am. J. Roentgenol."},{"issue":"1079","key":"70044_CR8","doi-asserted-by":"publisher","first-page":"20170361","DOI":"10.1259\/bjr.20170361","volume":"90","author":"A Chandramohan","year":"2017","unstructured":"Chandramohan, A., Thrower, A., Shah, N. & Mohamed, F. Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre. Br. J. Radiol.90(1079), 20170361. https:\/\/doi.org\/10.1259\/bjr.20170361 (2017).","journal-title":"Br. J. Radiol."},{"issue":"4","key":"70044_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jso.21055","volume":"98","author":"M Deraco","year":"2008","unstructured":"Deraco, M., Bartlett, D., Kusamura, S. & Baratti, D. Consensus statement on peritoneal mesothelioma. J. Surg. Oncol.98(4), 268\u2013272. https:\/\/doi.org\/10.1002\/jso.21055 (2008).","journal-title":"J. Surg. Oncol."},{"key":"70044_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet, P. & Sugarbaker, P. H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat. Res.82, 359\u2013374 (1996).","journal-title":"Cancer Treat. Res."},{"key":"70044_CR11","first-page":"49","volume":"15","author":"P Jacquet","year":"1996","unstructured":"Jacquet, P. & Sugarbaker, P. H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J. Exp. Clin. Cancer Res.15, 49\u201358 (1996).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"70044_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canep.2017.10.008","volume":"51","author":"SAS Salo","year":"2017","unstructured":"Salo, S. A. S. et al. Epidemiology of malignant peritoneal mesothelioma: a population-based study. Cancer Epidemiol.51, 81\u201386 (2017).","journal-title":"Cancer Epidemiol."},{"issue":"2","key":"70044_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.21873\/anticanres.13183","volume":"39","author":"SAS Salo","year":"2019","unstructured":"Salo, S. A. S. et al. Malignant peritoneal mesothelioma: treatment options and survival. Anticancer Res.39(2), 839\u2013845. https:\/\/doi.org\/10.21873\/anticanres.13183 (2019).","journal-title":"Anticancer Res."},{"issue":"9","key":"70044_CR14","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/cncr.25640","volume":"117","author":"TD Yan","year":"2011","unstructured":"Yan, T. D. et al. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer117(9), 1855\u20131863. https:\/\/doi.org\/10.1002\/cncr.25640 (2011).","journal-title":"Cancer"},{"issue":"4","key":"70044_CR15","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magge","year":"2014","unstructured":"Magge, D. et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann. Surg. Oncol.21(4), 1159\u20131165. https:\/\/doi.org\/10.1245\/s10434-013-3358-y (2014).","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"70044_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1245\/s10434-012-2651-5","volume":"20","author":"NP Schaub","year":"2013","unstructured":"Schaub, N. P. et al. A novel nomogram for peritoneal mesothelioma predicts survival. Ann. Surg. Oncol.20(2), 555\u2013561. https:\/\/doi.org\/10.1245\/s10434-012-2651-5 (2013).","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"70044_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/cncr.20836","volume":"103","author":"TD Yan","year":"2005","unstructured":"Yan, T. D., Haveric, N., Carmignani, C. P., Chang, D. & Sugarbaker, P. H. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer103(4), 839\u2013849. https:\/\/doi.org\/10.1002\/cncr.20836 (2005).","journal-title":"Cancer"},{"issue":"5","key":"70044_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/030089160509100503","volume":"91","author":"TD Yan","year":"2005","unstructured":"Yan, T. D., Haveric, N., Carmignani, C. P., Bromley, C. M. & Sugarbaker, P. H. Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori91(5), 394\u2013400 (2005).","journal-title":"Tumori"},{"issue":"5","key":"70044_CR19","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm, J. H. et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann. Surg. Oncol.22(5), 1686\u20131693. https:\/\/doi.org\/10.1245\/s10434-014-3978-x (2015).","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"70044_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.21037\/tlcr.2018.08.03","volume":"7","author":"PH Sugarbaker","year":"2018","unstructured":"Sugarbaker, P. H. Update on the management of malignant peritoneal mesothelioma. Transl. Lung Cancer Res.7(5), 599\u2013608. https:\/\/doi.org\/10.21037\/tlcr.2018.08.03 (2018).","journal-title":"Transl. Lung Cancer Res."},{"key":"70044_CR21","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.2147\/CMAR.S170300","volume":"11","author":"LM Enomoto","year":"2019","unstructured":"Enomoto, L. M., Shen, P., Levine, E. A. & Votanopoulos, K. I. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations. Cancer Manag. Res.11, 4231\u20134241. https:\/\/doi.org\/10.2147\/CMAR.S170300 (2019).","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"70044_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11605-014-2664-4","volume":"19","author":"S Jin","year":"2015","unstructured":"Jin, S. et al. Predictive factors analysis for malignant peritoneal mesothelioma. J. Gastrointest. Surg.19(2), 319\u2013326. https:\/\/doi.org\/10.1007\/s11605-014-2664-4 (2015).","journal-title":"J. Gastrointest. Surg."},{"issue":"2","key":"70044_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco, M. et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann. Surg. Oncol.13(2), 229\u2013237. https:\/\/doi.org\/10.1245\/ASO.2006.03.045 (2006).","journal-title":"Ann. Surg. Oncol."},{"issue":"36","key":"70044_CR24","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan, T. D. et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J. Clin. Oncol.27(36), 6237\u20136242. https:\/\/doi.org\/10.1200\/JCO.2009.23.9640 (2009).","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"70044_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/02841869409098430","volume":"33","author":"L Teppo","year":"1994","unstructured":"Teppo, L., Pukkala, E. & Lehtonen, M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol.33(4), 365\u2013369 (1994).","journal-title":"Acta Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70044-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70044-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70044-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:52:13Z","timestamp":1670345533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70044-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70044"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70044-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"21 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"13257"}}